Eqis Capital Management, Inc. Myriad Genetics Inc Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $379,899 - $464,702	-12,676 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$25.39 - $32.61 $2,945 - $3,782	116 Added 0.92%	12,676 $388,000
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $45,696 - $72,490	-2,294 Reduced 15.44%	12,560 $382,000
Q4 2020 Feb 11, 2021	BUY	$12.16 - $19.77 $32,442 - $52,746	2,668 Added 21.89%	14,854 $294,000
Q3 2020 Nov 10, 2020	BUY	$11.25 - $14.75 $1,687 - $2,212	150 Added 1.25%	12,186 $159,000
Q2 2020 Aug 10, 2020	SELL	$10.69 - $16.49 $24,031 - $37,069	-2,248 Reduced 15.74%	12,036 $136,000
Q1 2020 May 12, 2020	SELL	$9.78 - $29.53 $2,973 - $8,977	-304 Reduced 2.08%	14,284 $300,000
Q4 2019 Jan 24, 2020	SELL	$20.93 - $35.1 $69,236 - $116,110	-3,308 Reduced 18.48%	14,588 $397,000
Q3 2019 Nov 05, 2019	BUY	$22.08 - $47.08 $43,011 - $91,711	1,948 Added 12.21%	17,896 $512,000
Q2 2019 Jul 18, 2019	SELL	$22.67 - $35.0 $309,672 - $478,100	-13,660 Reduced 46.14%	15,948 $443,000
Q1 2019 Apr 18, 2019	BUY	$26.93 - $34.7 $111,921 - $144,213	4,156 Added 16.33%	29,608 $983,000
Q4 2018 Jan 25, 2019	SELL	$27.23 - $45.56 $278,208 - $465,486	-10,217 Reduced 28.64%	25,452 $740,000
Q3 2018 Oct 17, 2018	SELL	$37.57 - $50.34 $65,146 - $87,289	-1,734 Reduced 4.64%	35,669 $1.8 Million
Q2 2018 Jul 27, 2018	BUY	$27.75 - $40.17 $286,185 - $414,273	10,313 Added 38.07%	37,403 $1.4 Million
Q1 2018 Apr 06, 2018	BUY	$28.83 - $41.01 $31,222 - $44,413	1,083 Added 4.16%	27,090 $801,000
Q4 2017 Jan 25, 2018	SELL	$28.45 - $37.14 $6,088 - $7,947	-214 Reduced 0.82%	26,007 $893,000
Q3 2017 Oct 03, 2017	BUY	$24.01 - $36.2 $629,566 - $949,200	26,221	26,221 $949,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$232 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$158 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$103 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$79.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$72 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account